// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Donor-Bound Predictors for Primary Graft Function in Lung Transplantation - Results from a Prospective Multicenter Study

A. Benazzo - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Donor-Recipient Weight Mismatch and Primary Graft Dysfunction Risk Post-Lung Transplantation

A. Hirji - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Primary graft dysfunction

N/A

Recipient CD103+ Classical Dendritic Cells Enhance Acute Rejection in Response to Airway Inflammation after Mouse Lung Transplantation

T. Watanabe - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

N/A

Recipient HLA-G Single Nucleotide Polymorphisms Predict Post-Lung Development of Donor Specific Antibodies

D.C. Birriel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bronchoalveolar Lavage Pentraxin 3 Levels during Clinically-Stable Minimal Acute Rejection are Associated with CLAD and Death Risk

L. Levy - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

N/A

Does Left Atrial Appendage Occlusion in LVAD Patients Impact Outcomes: A Single Centre Study

F. Yu - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left atrial appendage occlusion

N/A

Variability in Donor Selection among Pediatric Heart Transplant Providers - Results from an International Survey

J. Godown - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Retransplantation: An Underutilized Resource or Only for a Select Few?

M. Vazquez Alvarez - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Functional Assessment of DCD Hearts Following Normothermic Regional Perfusion Can Predict Post-Transplantation Contractility

R. Ribeiro - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Gene Expression in Ex Vivo Perfused Porcine Hearts: Identification of a Molecular Injury-Repair Response

S. Rotich - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ghrelin, a Novel Growth Hormone-Releasing Peptide, Inhibits Inflammatory Response and Apoptosis during Ischemic Reperfusion Injury Following Murine Heart Transplantation

N. Fukunaga - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

hGH

Survival Outcomes in Heart Transplant Patients; Specific Focus on ACHD Patients and Their Outcomes as Compared to Dilated and Ischemic Cardiomyopathy Patients

A. Kinsella - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

N/A

Initial Experience with Non-Perfused Organ Donors for Lung Transplantation

Y. Watanabe - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Pre-Lung Transplant Waitlist Mortality Rate Reduction Using Remote Video Monitoring Technology

M. Zubrinic - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association between Serial Measurements of Tricuspid Annular Plane Systolic Excursion and Mortality Post Heart Transplant

J.K. Vishram-Nielsen - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Differential Gene Expression by Race and Impact on Risk after Heart Transplantation

Y. Moayedi - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tacrolimus

The Gift That Keeps on Giving? The Impact of Donor Coronary Atherosclerosis on the Development of Coronary Allograft Vasculopathy by IVUS

Y. Moayedi - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

Prednisone

Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients Treated with a Preemptive/ Targeted Antifungal Therapy Strategy: 4 Year Follow Up

S. Herrera - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Metabolic Alterations in Myocardial Metabolism during Ex Situ Heart Perfusion

S. Hatami - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Continuous Hemodialysis during Ex Vivo Lung Perfusion Allows for Improved Maintenance of Perfusate Composition, without Compromising Functional Performance

M.T. Buchko - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved